Use of Low-Dose IL-2 to expand endogenous regulatory T Cells and achieve transplantation tolerance

Project: Research

Project Details

StatusFinished
Effective start/end date15/02/201714/01/2021

Collaborative partners

Funding

  • MRC Medical Research Council: £821,817.00